Aristotle Atlantic Partners’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,218,025
| Closed | -$8.57M | – | 101 |
|
|
2023
Q2 | $8.57M | Buy |
1,218,025
+201,252
| +20% | +$1.42M | 0.32% | 65 |
|
|
2023
Q1 | $6.21M | Buy |
1,016,773
+8,337
| +0.8% | +$50.9K | 0.32% | 67 |
|
|
2022
Q4 | $6.44M | Sell |
1,008,436
-8,213
| -0.8% | -$52.5K | 0.36% | 66 |
|
|
2022
Q3 | $9.74M | Buy |
1,016,649
+5,840
| +0.6% | +$56K | 0.59% | 53 |
|
|
2022
Q2 | $11.2M | Buy |
1,010,809
+483,393
| +92% | +$5.34M | 0.86% | 32 |
|
|
2022
Q1 | $8.78M | Buy |
527,416
+1,878
| +0.4% | +$31.3K | 0.54% | 48 |
|
|
2021
Q4 | $10M | Buy |
+525,538
| New | +$10M | 0.58% | 42 |
|